抗下痢薬の世界市場2020-2026:処方薬、OTC薬

QYResearchが発行した調査報告書(QYR20AP00097)
◆英語タイトル:Global Anti Diarrheal Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP00097
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:110
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、抗下痢薬の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、抗下痢薬のグローバル市場動向、メーカー別競争状況、種類別市場規模(処方薬、OTC薬)、用途別市場規模(子ども、大人)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・抗下痢薬の種類別市場2015-2026:処方薬、OTC薬
・抗下痢薬の用途別市場2015-2026:子ども、大人
・抗下痢薬の北米市場分析
・抗下痢薬のアジア市場分析
・抗下痢薬の中南米市場分析
・抗下痢薬の中東・アフリカ市場分析
・関連企業情報:Actelion、Lupin、GSK、Glenmark Pharmaceuticals、Perrigo、Pfizer
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

In 2019, the global Anti Diarrheal Drugs market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Anti Diarrheal Drugs.The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Anti Diarrheal Drugs market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Anti Diarrheal Drugs market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Anti Diarrheal Drugs market. Readers of the report can become informed about current and future trends of the global Anti Diarrheal Drugs market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Anti Diarrheal Drugs markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Anti Diarrheal Drugs market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Anti Diarrheal Drugs market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Anti Diarrheal Drugs market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Anti Diarrheal Drugs market is segmented into
Prescription Drugs
OTC Drugs

Market Segment by Application, the Anti Diarrheal Drugs market is segmented into
Children
Adults

This report includes the following manufacturers; we can also add the other companies as you want.
Actelion
Lupin
GSK
Glenmark Pharmaceuticals
Perrigo
Pfizer

The study objectives are:
To analyze and research the global Anti Diarrheal Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Anti Diarrheal Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Anti Diarrheal Drugs are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Anti Diarrheal Drugs Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Anti Diarrheal Drugs Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Prescription Drugs
1.3.3 OTC Drugs
1.4 Market Segment by Application
1.4.1 Global Anti Diarrheal Drugs Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Children
1.4.3 Adults
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Anti Diarrheal Drugs Revenue (2015-2026)
2.1.1 Global Anti Diarrheal Drugs Revenue (2015-2026)
2.1.2 Global Anti Diarrheal Drugs Sales (2015-2026)
2.2 Anti Diarrheal Drugs Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Anti Diarrheal Drugs Sales by Regions (2015-2020)
2.2.2 Global Anti Diarrheal Drugs Revenue by Regions (2015-2020)
2.3 Global Top Anti Diarrheal Drugs Regions (Countries) Ranking by Market Size
2.4 Anti Diarrheal Drugs Industry Trends
2.4.1 Anti Diarrheal Drugs Market Top Trends
2.4.2 Market Drivers
2.4.3 Anti Diarrheal Drugs Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Anti Diarrheal Drugs Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Anti Diarrheal Drugs Manufacturers by Sales (2015-2020)
3.1.1 Global Anti Diarrheal Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Anti Diarrheal Drugs Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Anti Diarrheal Drugs Sales in 2019
3.2 Global Top Manufacturers Anti Diarrheal Drugs by Revenue
3.2.1 Global Anti Diarrheal Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Anti Diarrheal Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti Diarrheal Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti Diarrheal Drugs as of 2019)
3.4 Global Anti Diarrheal Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Anti Diarrheal Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Anti Diarrheal Drugs Market
3.7 Key Manufacturers Anti Diarrheal Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Anti Diarrheal Drugs Historic Market Review by Type (2015-2020)
4.1.2 Global Anti Diarrheal Drugs Sales Market Share by Type (2015-2020)
4.1.3 Global Anti Diarrheal Drugs Revenue Market Share by Type (2015-2020)
4.1.4 Anti Diarrheal Drugs Price by Type (2015-2020)
4.1 Global Anti Diarrheal Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Anti Diarrheal Drugs Sales Forecast by Type (2021-2026)
4.2.3 Global Anti Diarrheal Drugs Revenue Forecast by Type (2021-2026)
4.2.4 Anti Diarrheal Drugs Price Forecast by Type (2021-2026)

5 Global Anti Diarrheal Drugs Market Size by Application
5.1 Global Anti Diarrheal Drugs Historic Market Review by Application (2015-2020)
5.1.2 Global Anti Diarrheal Drugs Sales Market Share by Application (2015-2020)
5.1.3 Global Anti Diarrheal Drugs Revenue Market Share by Application (2015-2020)
5.1.4 Anti Diarrheal Drugs Price by Application (2015-2020)
5.2 Global Anti Diarrheal Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Anti Diarrheal Drugs Sales Forecast by Application (2021-2026)
5.2.3 Global Anti Diarrheal Drugs Revenue Forecast by Application (2021-2026)
5.2.4 Anti Diarrheal Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Anti Diarrheal Drugs Breakdown Data by Company
6.2 North America Anti Diarrheal Drugs Breakdown Data by Type
6.3 North America Anti Diarrheal Drugs Breakdown Data by Application
6.4 North America Anti Diarrheal Drugs Breakdown Data by Countries
6.4.1 North America Anti Diarrheal Drugs Sales by Countries
6.4.2 North America Anti Diarrheal Drugs Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Anti Diarrheal Drugs Breakdown Data by Company
7.2 Europe Anti Diarrheal Drugs Breakdown Data by Type
7.3 Europe Anti Diarrheal Drugs Breakdown Data by Application
7.4 Europe Anti Diarrheal Drugs Breakdown Data by Countries
7.4.1 Europe Anti Diarrheal Drugs Sales by Countries
7.4.2 Europe Anti Diarrheal Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Anti Diarrheal Drugs Breakdown Data by Company
8.2 Asia Pacific Anti Diarrheal Drugs Breakdown Data by Type
8.3 Asia Pacific Anti Diarrheal Drugs Breakdown Data by Application
8.4 Asia Pacific Anti Diarrheal Drugs Breakdown Data by Regions
8.4.1 Asia Pacific Anti Diarrheal Drugs Sales by Regions
8.4.2 Asia Pacific Anti Diarrheal Drugs Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Anti Diarrheal Drugs Breakdown Data by Company
9.2 Latin America Anti Diarrheal Drugs Breakdown Data by Type
9.3 Latin America Anti Diarrheal Drugs Breakdown Data by Application
9.4 Latin America Anti Diarrheal Drugs Breakdown Data by Countries
9.4.1 Latin America Anti Diarrheal Drugs Sales by Countries
9.4.2 Latin America Anti Diarrheal Drugs Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Anti Diarrheal Drugs Breakdown Data by Type
10.2 Middle East and Africa Anti Diarrheal Drugs Breakdown Data by Application
10.3 Middle East and Africa Anti Diarrheal Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Anti Diarrheal Drugs Sales by Countries
10.3.2 Middle East and Africa Anti Diarrheal Drugs Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Actelion
11.1.1 Actelion Corporation Information
11.1.2 Actelion Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Actelion Anti Diarrheal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Actelion Anti Diarrheal Drugs Products and Services
11.1.5 Actelion SWOT Analysis
11.1.6 Actelion Recent Developments
11.2 Lupin
11.2.1 Lupin Corporation Information
11.2.2 Lupin Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Lupin Anti Diarrheal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Lupin Anti Diarrheal Drugs Products and Services
11.2.5 Lupin SWOT Analysis
11.2.6 Lupin Recent Developments
11.3 GSK
11.3.1 GSK Corporation Information
11.3.2 GSK Business Overview and Total Revenue (2019 VS 2018)
11.3.3 GSK Anti Diarrheal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 GSK Anti Diarrheal Drugs Products and Services
11.3.5 GSK SWOT Analysis
11.3.6 GSK Recent Developments
11.4 Glenmark Pharmaceuticals
11.4.1 Glenmark Pharmaceuticals Corporation Information
11.4.2 Glenmark Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Glenmark Pharmaceuticals Anti Diarrheal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Glenmark Pharmaceuticals Anti Diarrheal Drugs Products and Services
11.4.5 Glenmark Pharmaceuticals SWOT Analysis
11.4.6 Glenmark Pharmaceuticals Recent Developments
11.5 Perrigo
11.5.1 Perrigo Corporation Information
11.5.2 Perrigo Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Perrigo Anti Diarrheal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Perrigo Anti Diarrheal Drugs Products and Services
11.5.5 Perrigo SWOT Analysis
11.5.6 Perrigo Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Pfizer Anti Diarrheal Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Pfizer Anti Diarrheal Drugs Products and Services
11.6.5 Pfizer SWOT Analysis
11.6.6 Pfizer Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Anti Diarrheal Drugs Sales Channels
12.2.2 Anti Diarrheal Drugs Distributors
12.3 Anti Diarrheal Drugs Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Anti Diarrheal Drugs Sales Forecast (2021-2026)
13.1.1 Global Anti Diarrheal Drugs Sales Forecast by Regions (2021-2026)
13.1.2 Global Anti Diarrheal Drugs Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Anti Diarrheal Drugs Sales Forecast (2021-2026)
13.2.2 North America Anti Diarrheal Drugs Revenue Forecast (2021-2026)
13.2.3 North America Anti Diarrheal Drugs Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Anti Diarrheal Drugs Sales Forecast (2021-2026)
13.3.2 Europe Anti Diarrheal Drugs Revenue Forecast (2021-2026)
13.3.3 Europe Anti Diarrheal Drugs Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Anti Diarrheal Drugs Sales Forecast (2021-2026)
13.4.2 Asia Pacific Anti Diarrheal Drugs Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Anti Diarrheal Drugs Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Anti Diarrheal Drugs Sales Forecast (2021-2026)
13.5.2 Latin America Anti Diarrheal Drugs Revenue Forecast (2021-2026)
13.5.3 Latin America Anti Diarrheal Drugs Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Anti Diarrheal Drugs Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Anti Diarrheal Drugs Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Anti Diarrheal Drugs Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Actelion、Lupin、GSK、Glenmark Pharmaceuticals、Perrigo、Pfizer

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 抗下痢薬の世界市場2020-2026:処方薬、OTC薬(Global Anti Diarrheal Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。